About the Exhibitors

CounterX Therapeutics is at the forefront of the battle against the opioid epidemic, exploiting cutting-edge biotechnology to develop life-saving therapeutics and vaccines. We combine scientific expertise with an experienced leadership team and a deep commitment to social impact. Our groundbreaking antibody therapies are designed to blunt the effects of opioids, reduce the risk of overdose and a provide a path to recovery. Additionally, our pioneering vaccine technology aims to prevent addiction relapse by blocking the euphoric effects of opioids and to empowering individuals to maintain a long-term recovery.
Register Free
By submitting your email address you agree to receive emails on MoneyShow events, special offers, and updates.
Exhibitor Schedule
Tuesday, April 21, 2026, 2:50 pm - 3:20 pm EST
CounterX Therapeutics: Ending the Fentanyl Overdose Epidemic
Shawn Iadonato |CounterX Therapeutics

Overdose from illicit fentanyl is the leading cause of death for working-age Americans. CounterX Therapeutics is committed to ending the fentanyl overdose epidemic and offering hope to individuals, families and communities devastated by this crisis. CounterX Therapeutics is developing CTRX-101, a once-monthly treatment that blocks fentanyl's lethal effects and prevents overdose. Supported by over $40M in NIH funding, we are positioned to address a critical public health crisis with a potential market of ~3.1M patients and peak-year sales of $4.6B.

Reserve Your Free Pass Today!